+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Strontium-89"

Radiotheranostics Global Market Report 2024 - Product Thumbnail Image

Radiotheranostics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Strontium-89 (CAS 14158-27-1) Global Market Research Report 2024 - Product Thumbnail Image

Strontium-89 (CAS 14158-27-1) Global Market Research Report 2024

  • Report
  • May 2024
  • 50 Pages
  • Global
From
Radiopharmaceuticals Market By Radioisotope, By Application, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Radiopharmaceuticals Market By Radioisotope, By Application, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • April 2023
  • 300 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Strontium-89 is a radiopharmaceutical used in Nuclear Medicine and Radiopharmacology. It is a radioactive isotope of strontium, and is used to treat bone pain caused by metastatic prostate cancer. It is administered intravenously, and is taken up by the bone, where it emits beta radiation to reduce pain. Strontium-89 is also used to diagnose bone metastases, and to monitor the effectiveness of treatments. The Strontium-89 market is composed of companies that produce and distribute the radiopharmaceutical. These companies include Eckert & Ziegler, Jubilant DraxImage, IBA Molecular, and Nordion. Show Less Read more